Search results
Albert Bourla
Time Magazine· 17 hours agoWhen Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. “No...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 7 days agoDive Brief: The Food and Drug Administration on Friday approved a new gene therapy for hemophilia,...
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via AOL· 2 days agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
Q1 2024 Pfizer Inc Earnings Call Transcript
Guru Focus· 2 days agoMay 01, 2024 / 02:00PM GMTOperator Good day, everyone, and welcome to Pfizer's First Quarter 2024 Earnings Conference Call. Today's call is being recorded. At t
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 2 days agoFull-Year Guidance: Adjusted EPS guidance raised to $2.15 to $2.35, reaffirms revenue guidance of...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 3 days agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 2 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 2 days agoPfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 2 days agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...